Please login to the form below

Not currently logged in
Email:
Password:

Pipeline

This page shows the latest Pipeline news and features for those working in and with pharma, biotech and healthcare.

New leader at Medivir after setbacks

New leader at Medivir after setbacks

Christine Lind has been replaced by Uli Hacksell. Medivir has suffered a couple of recent pipeline setbacks in the summer, it was forced to delay a pivotal clinical trials programme for ... Along with remetinostat, Medivir’s clinical pipeline includes

Latest news

More from news
Approximately 16 fully matching, plus 1,134 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 126 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    Gaweco will lead Apeiron’s immuno-oncology programmes, overseeing the discovery, clinical and medical functions of the company’s new molecular entities pipeline of cancer immunotherapies. ... Peter Llewellyn-Davies, President and CEO of Apeiron, said:

  • Industry appointments Industry appointments

    reasons. Although Wotton will remain on the board, Vivaldi will be moving the company towards its goal of commercialising its multi-product pipeline. ... I look forward to advancing the company's vision, mission and promising pipeline to meaningfully

  • Biogen appoints executive VP, corporate development Biogen appoints executive VP, corporate development

    Daniel's solid experience from Pfizer combined with his scientific and business education will serve him well in this exciting position as we aim to further build our pipeline and portfolio

  • Axovant poaches Allergan’s and Teva’s chief medical and science officers Axovant poaches Allergan’s and Teva’s chief medical and science officers

    I am also eager to leverage the Roivant platform to accelerate the development of Axovant’s pipeline.”. ... We are now poised for growth, and I am excited to have Gavin and Michael join us as we look toward expanding our pipeline in the coming months.

  • Kevin Sin joins GSK Kevin Sin joins GSK

    In this position, Sin will play a role in strengthening GSK’s pharmaceutical pipeline and identifying enabling technologies to enhance delivery of new medicines for patients.

More from appointments
Approximately 0 fully matching, plus 177 partially matching documents found.

Latest from PMHub

  • The gene therapy revolution

    In the last few years, we have seen treatment possibilities expand and, looking at the current pipeline of drugs heading in the direction of the regulatory bodies in the coming months

  • Using contextual moments in marketing

    Create a contextual moment and content pipeline. With many possible events and moments that can be utilised, it’ s important to include a range of prompts that will trigger ads to

  • Training the next generation of biotech leaders

    It would be nice to think that in the next ten to fifteen years, we’ ll see a pipeline of new medicines emerging off the back of these early successes, like

  • Rapid Payer Response Early Pipeline Case Study

    Rapid Payer Response Early Pipeline Case Study. Downloads. . ... RPR Early Pipeline Case Study.

  • Market Access Transformation

    Market Access Transformation. MAT offers an online, information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and feedback from the largest and most diverse online payer resource

More from PMHub
Approximately 1 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics